Cell counting is required in medicine as well as biological research. In medicine, it is required to calculate the concentration of blood cells such as white blood cells (WBCs) and red blood cells (RBCs) and concentration of bacteria, viruses to find out information regarding infectious diseases. Cell counting market is expected to witness lucrative growth in future as it is used by research institutes, hospitals, biotech and pharmaceuticals companies as an important tool in research, drug discovery and biopharmaceutical applications. Other important factors such as an increasing prevalence of cancer patients, and government funding for development and research are expected to further fuel demand in the cell counting market. In 2014, Agilent Technologies and Cell Line Genetics of U.S collaborated for the higher rate of screening of cell line for regenerative medicine. The use of genomic characterizations, high throughput screening, and research into cell line integrity for regenerative and translational medicine research is expected to drive demand though to 2022.
The cell counting applications include cell structure study and cell analysis, quality control, cell-viability, proliferation, signalling, identification, and single cell analysis. The applications for cell identification include identification of blood cells, identification on the basis of their size and other morphological features like presence or absence of cell nucleus and nucleus shape. Cell identification also includes examination of tumour cell using microfluidics and Raman spectroscopy. The products offered in the market include instruments and consumables. Instruments used for cell analysis market include cell counting instruments, cell microarrays, qRT-PCR, flow cytometer, spectrophotometer, microscopes. Consumables used in the cell counting market are required for sample preparation and cell culture techniques and include reagents, assay kits, micro plates and other consumables. It is expected that cell counting instruments will witness a steady growth in demand throughout the forecast period owing to the growing demand for cell counting applications.
The geographical analysis for cell counting market divides it into North America, Europe, Asia-Pacific and Latin America and MEA. North America accounted for the largest share of revenue for 2014. Asia-pacific is expected to grow at significant rate in the next seven years. This expected growth can be attributed to the increasing incidence of cancer, infectious and chronic diseases, and enhancement of healthcare services. Developments such as the German government, collaboration with Biomet network to fund the Max Planck Institute of Molecular Cell Biology and Genetics (Germany) for enhancing high content screening in Europe is are also expected to fuel global demand.
The global cell analysis market is highly competitive because of well established firms and efforts made by new entrants to occupy market share. The key participants in the market are Advanced Cell Technologies Inc., Athersys, Celgene Corporation, Cellular Dynamics International, Cytori Therapeutics Inc., Fibrocell Science, Gamida Cell Limited, Mesoblast Limited, Pluristem Therapeutics Inc., Stemcells, and Aastrom Biosciences Inc.
Grand View Research offers special pricing for:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.